Factors influencing circulating microRNA level in the studies of hepatocellular carcinoma biomarker

Neoplasma

Volumn 62, Issue 5, 2015, Pages 798-804

  Wang, Y ^a   Liang, Z ^b   Gao, Y ^c   Zhai, D ^c   Rao, Q ^a   Shi, W ^c   Yang, B ^c   Jing, L ^c   Guo, H ^c   Liu, T ^c   Liu, J ^a   Du, Z ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b People Hospital of Cangzhou   (China)

^c TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

Disease status; Extraction; Plasma; qRT PCR; Serum

Indexed keywords

MICRORNA; MICRORNA 183; MICRORNA 39; MICRORNA U6; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC KIT; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PLASMA; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 84943611932     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_096     Document Type: Article

References (37)

1. Giordano S, Columbano A. “MicroRNAs: new tools for diagnosis, prognosis and therapy in HCC?” Hepatology 2013; 57: 840–847. http://dx.doi.org/10.1002/hep.26095
2. HENEGHAN HM, MILLER N, LOWERY AJ, SWEENEY KJ, NEWELL J, et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499–505. http://dx.doi.org/10.1097/SLA.0b013e3181cc939f
3. CHIN LJ, SLACK FJ. A truth serum for cancer--microRNAs have major potential as cancer biomarkers. Cell Res 2008; 18: 983–984. http://dx.doi.org/10.1038/cr.2008.290
4. CHEN X, BA Y, MA L, CAI X, YIN Y, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997–1006. http://dx.doi.org/10.1038/cr.2008.282
5. MITCHELL PS, PARKIN RK, KROH EM, FRITZ BR, WYMAN SK, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513–8. http://dx.doi.org/10.1073/pnas.0804549105
6. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3: e3148. http://dx.doi.org/10.1371/journal.pone.0003148
7. CHEN Y, GELFOND JA, MCMANUS LM, SHIREMAN PK. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 2009; 10: 407. http://dx.doi.org/10.1186/1471-2164-10-407
8. TOMIMARU Y, EGUCHI H, NAGANO H, WADA H, KOBAYASHI S, et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 2012; 56: 167–75. http://dx.doi.org/10.1016/j.jhep.2011.04.026
9. LI LM, HU ZB, ZHOU ZX, CHEN X, LIU FY, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010; 70: 9798–807. http://dx.doi.org/10.1158/0008-5472.CAN-10-1001
10. ZHOU J, YU L, GAO X, HU J, WANG J, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29: 4781–8. http://dx.doi.org/10.1200/JCO.2011.38.2697
11. XU J, WU C, CHE X, WANG L, YU D, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011; 50: 136–42. http://dx.doi.org/10.1002/mc.20712
12. XU J, ZHU X, WU L, YANG R, YANG Z, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int 2012; 32: 752–60. http://dx.doi.org/10.1111/j.1478-3231.2011.02750.x
13. Qi P, Cheng SQ, Wang H, Li N, Chen YF, et al. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011; 6: e28486. http://dx.doi.org/10.1371/journal.pone.0028486
14. Li J, Wang Y, Yu W, Chen J, Luo J. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys. Res Commun 2011; 406: 70–3. http://dx.doi.org/10.1016/j.bbrc.2011.01.111
15. Page K, Guttery DS, Zahra N, Primrose L, Elshaw SR, et al. Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One 2013; 8: e77963. http://dx.doi.org/10.1371/journal.pone.0077963
16. ELDH M, LOTVALL J, MALMHÄLL C, EKSTROM K. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol 2012; 50: 278–86. http://dx.doi.org/10.1016/j.molimm.2012.02.001
17. MCALEXANDER MA, PHILLIPS MJ, WITWER KW. Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid. Front Genet 2013; 4: 83. http://dx.doi.org/10.3389/fgene.2013.00083
18. ACH RA, WANG H, CURRY B. Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol 2008; 8: 69. http://dx.doi.org/10.1186/1472-6750-8-69
19. MCDONALD JS, MILOSEVIC D, REDDI HV, GREBE SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011; 57: 833–40. http://dx.doi.org/10.1373/clinchem.2010.157198
20. Wang K, Yuan Y, Cho JH, Mcclarty S, Baxter D, et al. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012; 7(7): e41561. http://dx.doi.org/10.1371/journal.pone.0041561
21. Johnson ML, Navanukraw C, Grazul-Bilska AT, Reynolds LP, Redmer DA. Heparinase treatment of RNA before quantitative real-time RT-PCR. Biotechniques 2003; 35: 1140–2, 1144.
22. BAI X, FISCHER S, KESHAVJEE S, LIU M. Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion. Transpl Int 2000; 13: 146–50. http://dx.doi.org/10.1111/j.1432-2277.2000.tb01055.x
23. Garcia ME, Blanco JL, Caballero J, Gargallo-Viola D. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol 2002; 40: 1567–8. http://dx.doi.org/10.1128/JCM.40.4.1567-1568.2002
24. HASTINGS ML, PALMA J, DUELLI DM. Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods 2012; 58: 144–50. http://dx.doi.org/10.1016/j.ymeth.2012.07.026
25. KIM DJ, LINNSTAEDT S, PALMA J, PARK JC, NTRIVALAS E, et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn 2012; 14: 71–80. http://dx.doi.org/10.1016/j.jmoldx.2011.09.002
26. Costa MC, Leitao AL, Enguita FJ. MicroRNA Profiling in Plasma or Serum Using Quantitative RT-PCR. Methods Mol Biol 2014; 1182: 121–9. http://dx.doi.org/10.1007/978-1-4939-1062-5_11
27. PRITCHARD CC, KROH E, WOOD B, ARROYO JD, DOUGHERTY KJ, et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies. Cancer Prev Res (Phila) 2012; 5: 492–7. http://dx.doi.org/10.1158/1940-6207.CAPR-11-0370
28. Li J, Shi W, Gao Y, Yang B, Jing X, et al. Analysis of MicroRNA ExpressionProfiles in Human Hepatitis B Virus-Related Hepatocellular Carcinoma. Clin Lab 2013; 59: 1009–15.
29. LIANG Z, GAO Y, SHI W, ZHAI D, LI S, et al. Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma. ScientificWorldJournal 2013; 2013: 381874. http://dx.doi.org/10.1155/2013/381874
30. JIANG J, LEE EJ, GUSEV Y, SCHMITTGEN TD. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 2005; 33: 5394–403. http://dx.doi.org/10.1093/nar/gki863
31. AMBS S, PRUEITT RL, YI M, HUDSON RS, HOWE TM, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162–70. http://dx.doi.org/10.1158/0008-5472.CAN-08-0144
32. SCHAEFER A, JUNG M, MILLER K, LEIN M, KRISTIANSEN G, et al. Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 2010; 42: 749–58. http://dx.doi.org/10.3858/emm.2010.42.11.076
33. FARINA NH, WOOD ME, PERRAPATO SD, FRANCKLYN CS, STEIN GS, et al. Standardizing Analysis of Circulating MicroRNA: Clinical and Biological Relevance. J Cell Biochem 2014; 115: 805–11. http://dx.doi.org/10.1002/jcb.24745
34. MACLELLAN SA, MACAULAY C, LAM S, GARNIS C. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol 2014; 14: 27. http://dx.doi.org/10.1186/1472-6890-14-27
35. MCALEXANDER MA, PHILLIPS MJ, WITWER KW. Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front Genet 2013; 4: 83. http://dx.doi.org/10.3389/fgene.2013.00083
36. LIVAK KJ, SCHMITTGEN TD. Analysis of Relative Gene Expression Data Using RealTime Quantitative PCR and the 2-ΔΔCT Method. Methods 2001; 25: 402–8. http://dx.doi.org/10.1006/meth.2001.1262
37. BAKER M. MicroRNA profiling: separating signal from noise. Nat Methods 2010; 7: 687–692. http://dx.doi.org/10.1038/nmeth0910-687